Predictive Oncology (POAI) Short Interest Ratio & Short Volume $1.45 -0.02 (-1.36%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.34%) As of 02/21/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Predictive Oncology Short Interest DataPredictive Oncology (POAI) has a short interest of 626,700 shares, representing 9.55% of the float (the number of shares available for trading by the public). This marks a 36.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 3.69 million shares to cover all short positions.Current Short Interest626,700 sharesPrevious Short Interest457,800 sharesChange Vs. Previous Month+36.89%Dollar Volume Sold Short$921,249.00Short Interest Ratio0.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares6,670,000 sharesFloat Size6,560,000 sharesShort Percent of Float9.55%Today's Trading Volume215,174 sharesAverage Trading Volume3,690,940 sharesToday's Volume Vs. Average6% Short Selling Predictive Oncology? Sign up to receive the latest short interest report for Predictive Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPOAI Short Interest Over TimePOAI Days to Cover Over TimePOAI Percentage of Float Shorted Over Time Predictive Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025626,700 shares $921,249.00 +36.9%9.6%0.3 $1.47 1/15/2025457,800 shares $544,782.00 +224.2%7.0%0.2 $1.19 12/31/2024141,200 shares $115,784.00 +7.4%2.2%0.1 $0.82 12/15/2024131,500 shares $102,556.85 -9.4%2.0%1.3 $0.78 11/30/2024145,100 shares $116,805.50 -9.6%2.2%1.4 $0.81 11/15/2024160,500 shares $110,199.30 +7.7%2.5%1.5 $0.69 10/31/2024149,000 shares $106,892.60 -7.6%2.3%1.3 $0.72 10/15/2024161,300 shares $88,731.13 +56.8%2.5%0.1 $0.55 9/30/2024102,900 shares $81,085.20 +60.5%1.6%0 $0.79 9/15/202464,100 shares $57,690.00 -18.0%1.0%0 $0.90 Get the Latest News and Ratings for POAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/31/202478,200 shares $74,759.20 -3.6%1.2%0 $0.96 8/15/202481,100 shares $76,055.58 -62.5%1.3%0 $0.94 7/31/2024216,400 shares $244,532.00 +1,039.0%5.5%0.1 $1.13 7/15/202419,000 shares $21,090.00 -63.5%0.5%0 $1.11 6/30/202452,000 shares $54,080.00 -32.4%1.3%0 $1.04 6/15/202476,900 shares $93,818.00 -71.1%2.0%0 $1.22 5/31/2024265,900 shares $380,237.00 +121.0%6.7%0.2 $1.43 5/15/2024120,300 shares $209,322.00 +484.0%3.1%0.7 $1.74 4/30/202420,600 shares $29,458.00 +58.5%0.5%0.1 $1.43 4/15/202413,000 shares $19,630.00 -49.0%0.3%0.4 $1.51 3/31/202425,500 shares $65,025.00 +129.7%0.7%1.1 $2.55 3/15/202411,100 shares $29,304.00 -37.6%0.3%0.5 $2.64 2/29/202417,800 shares $54,824.00 -31.5%0.5%0.9 $3.08 2/15/202426,000 shares $84,500.00 -19.3%0.7%1.3 $3.25 1/31/202432,200 shares $98,854.00 -8.3%0.8%1.9 $3.07 1/15/202435,100 shares $101,088.00 -33.7%0.9%1.9 $2.88 12/31/202352,900 shares $174,041.00 -15.5%1.4%2.9 $3.29 12/15/202362,600 shares $197,816.00 -26.4%1.6%3.6 $3.16 11/30/202385,000 shares $277,950.00 -13.6%2.2%4.5 $3.27 11/15/202398,400 shares $306,024.00 -4.7%2.5%4.9 $3.11 10/31/2023103,200 shares $309,600.00 -13.5%2.7%4.3 $3.00 10/15/2023119,300 shares $472,428.00 -5.5%3.1%3.9 $3.96 9/30/2023126,300 shares $404,160.00 -32.1%3.2%2.7 $3.20 9/15/2023186,000 shares $597,060.00 -29.7%4.8%2.4 $3.21 8/31/2023264,400 shares $1.14 million -7.8%6.8%2.7 $4.32 8/15/2023286,900 shares $1.37 million -4.9%7.4%2.4 $4.76 7/31/2023301,700 shares $1.75 million -0.5%7.8%2.1 $5.80 7/15/2023303,200 shares $1.77 million +16.3%7.8%1.5 $5.84 6/30/2023260,800 shares $1.27 million +123.7%6.7%1.1 $4.86 6/15/2023116,600 shares $402,270.00 -11.1%3.0%0.5 $3.45Top Picks for Trump’s Pro-Crypto America (Ad)10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Click here to claim your FREE ticket 5/31/2023131,100 shares $423,453.00 +40.7%3.4%0.7 $3.23 5/15/202393,200 shares $318,744.00 -49.1%2.5%0.6 $3.42 4/30/2023183,100 shares $520,004.00 +421.7%4.9%1.3 $2.84 4/15/202335,100 shares $266,760.00 -84.3%N/A0.3 $7.60 3/31/2023223,500 shares $73,039.80 +6.9%N/A0.5 $0.33 3/15/2023209,000 shares $68,970.00 -25.3%N/A0.5 $0.33 2/28/2023279,600 shares $119,109.60 +17.1%N/A0.7 $0.43 2/15/2023238,800 shares $103,639.20 -42.8%N/A0.6 $0.43 1/31/2023417,100 shares $221,063.00 +64.0%N/A1 $0.53 1/15/2023254,300 shares $122,699.75 +14.2%N/A0.7 $0.48 12/30/2022222,700 shares $68,279.82 -4.6%N/A0.7 $0.31 12/15/2022233,500 shares $94,007.10 +89.7%N/A0.7 $0.40 11/30/2022123,100 shares $47,405.81 +68.9%N/A0.4 $0.39 11/15/202272,900 shares $19,865.25 -63.7%N/A0.3 $0.27 10/31/2022201,000 shares $54,772.50 +50.9%N/A0.8 $0.27 10/15/2022133,200 shares $40,639.32 -32.4%N/A0.6 $0.31 9/30/2022196,900 shares $70,884.00 +6.4%N/A0.7 $0.36 9/15/2022185,100 shares $71,300.52 +10.4%N/A0.6 $0.39 8/31/2022167,600 shares $67,576.32 -5.6%N/A0.5 $0.40 8/15/2022177,600 shares $77,273.76 -10.6%N/A0.2 $0.44 7/31/2022198,700 shares $81,546.48 -11.9%N/A0.2 $0.41 7/15/2022225,600 shares $94,752.00 -5.9%N/A0.2 $0.42 6/30/2022239,800 shares $98,341.98 +29.5%N/A0.2 $0.41 6/15/2022185,200 shares $72,357.64 -63.2%N/A0.2 $0.39 5/31/2022502,900 shares $184,312.85 -32.1%N/A0.5 $0.37 5/15/2022740,700 shares $517,675.23 +1.7%N/A0.8 $0.70 4/30/2022728,000 shares $526,344.00 +4.8%N/A2.3 $0.72 4/15/2022694,500 shares $541,015.50 -25.9%N/A1.9 $0.78 3/31/2022936,800 shares $915,253.60 -13.3%N/A2.1 $0.98 3/15/20221,080,000 shares $993,600.00 +6.9%N/A2.5 $0.92 2/28/20221,010,000 shares $791,436.00 -4.7%N/A2.2 $0.78 2/15/20221,060,000 shares $826,800.00 -26.9%N/A2 $0.78 1/31/20221,450,000 shares $1.28 million +39.4%N/A2.4 $0.88 1/15/20221,040,000 shares $926,536.00 -1.0%N/A1.5 $0.89 12/31/20211,050,000 shares $999,495.00 -18.6%N/A1.5 $0.95 12/15/20211,290,000 shares $1.26 million +14.2%N/A1 $0.98 11/30/20211,130,000 shares $1.16 million +9.7%N/A0.6 $1.03 11/15/20211,030,000 shares $1.19 million +2.0%N/A0.6 $1.16 10/29/20211,010,000 shares $1.27 million -30.8%N/A0.5 $1.26 10/15/20211,460,000 shares $1.77 million +1.4%N/A0.8 $1.21 9/30/20211,440,000 shares $1.92 million -8.9%N/A0.7 $1.33 9/15/20211,580,000 shares $1.56 million -15.5%N/A0.7 $0.99 8/31/20211,870,000 shares $2.00 million +0.5%N/A0.7 $1.07 8/13/20211,860,000 shares $1.92 million +35.8%N/A0.7 $1.03 7/30/20211,370,000 shares $1.55 million -9.3%N/A0.5 $1.13 7/15/20211,510,000 shares $1.81 million +2.0%N/A0.5 $1.20 6/30/20211,480,000 shares $1.94 million -32.1%N/A0.5 $1.31 6/15/20212,180,000 shares $2.25 million -37.7%4.8%0.8 $1.03 5/28/20213,500,000 shares $4.13 million -20.8%7.7%1.5 $1.18 5/14/20214,420,000 shares $3.71 million -6.8%N/A1.6 $0.84Top Picks for Trump’s Pro-Crypto America (Ad)10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Click here to claim your FREE ticket 4/30/20214,740,000 shares $5.31 million +69.9%N/A1.2 $1.12 4/15/20212,790,000 shares $3.29 million -8.8%N/A0.6 $1.18 3/31/20213,060,000 shares $3.43 million -15.9%N/A0.6 $1.12 3/15/20213,640,000 shares $6.08 million -2.4%N/A0.8 $1.67 2/26/20213,730,000 shares $5.48 million +326.7%N/A0.9 $1.47 2/12/2021874,100 shares $1.62 million +20.6%N/A0.2 $1.85 1/29/2021724,900 shares $855,382.00 -5.8%2.7%0.3 $1.18 1/15/2021769,100 shares $714,186.26 +79.6%2.9%0.4 $0.93 12/31/2020428,200 shares $298,412.58 +58.6%2.8%0.4 $0.70 12/15/2020270,000 shares $195,750.00 -14.6%1.7%0.4 $0.73 11/30/2020316,000 shares $233,840.00 -7.9%2.1%0.3 $0.74 11/15/2020343,200 shares $239,519.28 -38.1%2.2%0.3 $0.70 10/30/2020554,400 shares $398,613.60 +44.2%4.2%0.5 $0.72 10/15/2020384,600 shares $305,333.94 +24.3%2.9%0.3 $0.79 9/30/2020309,400 shares $251,882.54 -19.1%2.4%0.2 $0.81 9/15/2020382,400 shares $328,864.00 +36.5%2.9%0.3 $0.86 8/31/2020280,200 shares $302,616.00 +4.5%2.2%0.3 $1.08 8/14/2020268,200 shares $362,070.00 -21.0%2.1%0.3 $1.35 7/31/2020339,400 shares $549,828.00 +96.3%2.9%0.3 $1.62 7/15/2020172,900 shares $248,976.00 -7.4%1.6%0.2 $1.44 6/30/2020186,800 shares $306,352.00 -45.7%2.1%0.2 $1.64 6/15/2020344,100 shares $574,647.00 +5.3%4.3%0.4 $1.67 5/29/2020326,900 shares $503,426.00 +38.6%4.2%0.3 $1.54 5/15/2020235,900 shares $330,260.00 +5.9%3.5%0.2 $1.40 4/30/2020222,800 shares $329,744.00 -19.6%5.7%0.3 $1.48 4/15/2020277,200 shares $462,924.00 +175.8%5.4%0.5 $1.67 3/31/2020100,500 shares $131,655.00 -6.7%2.1%0.2 $1.31 3/13/2020107,700 shares $150,780.00 +30.1%3.4%0.1 $1.40 2/28/202082,800 shares $113,436.00 +1.7%2.6%0.5 $1.37 POAI Short Interest - Frequently Asked Questions What is Predictive Oncology's current short interest? Short interest is the volume of Predictive Oncology shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 626,700 shares of POAI short. 9.55% of Predictive Oncology's shares are currently sold short. Learn More on Predictive Oncology's current short interest. What is a good short interest percentage for Predictive Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.55% of Predictive Oncology's floating shares are currently sold short. Is Predictive Oncology's short interest increasing or decreasing? Predictive Oncology saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 626,700 shares, an increase of 36.9% from the previous total of 457,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Predictive Oncology's float size? Predictive Oncology currently has issued a total of 6,670,000 shares. Some of Predictive Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Predictive Oncology currently has a public float of 6,560,000 shares. How does Predictive Oncology's short interest compare to its competitors? 9.55% of Predictive Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Predictive Oncology: NeuroOne Medical Technologies Co. (0.50%), Daxor Co. (0.60%), Beyond Air, Inc. (1.24%), Precision Optics Co., Inc. (0.49%), PolyPid Ltd. (0.21%), Envoy Medical, Inc. (1.25%), SurgePays, Inc. (3.00%), DIH Holding US, Inc. (2.89%), IRIDEX Co. (2.39%), Femasys Inc. (0.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Predictive Oncology stock? Short selling POAI is an investing strategy that aims to generate trading profit from Predictive Oncology as its price is falling. POAI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Predictive Oncology? A short squeeze for Predictive Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of POAI, which in turn drives the price of the stock up even further. How often is Predictive Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including POAI, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies NeuroOne Medical Technologies Short Squeeze Daxor Short Squeeze Beyond Air Short Squeeze Precision Optics Short Squeeze PolyPid Short Squeeze Envoy Medical Short Squeeze SurgePays Short Squeeze DIH Holding US Short Squeeze IRIDEX Short Squeeze Femasys Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:POAI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.